Edited by Ruma BanerjeeThe high-affinity biosynthetic pathway for converting acetate to acetyl-coenzyme A (acetyl-CoA) is catalyzed by the central metabolic enzyme acetyl-coenzyme A synthetase (Acs), which is finely regulated both at the transcriptional level via cyclic AMP (cAMP)-driven trans-activation and at the post-translational level via acetylation inhibition. In this study, we discovered that cAMP directly binds to Salmonella enterica Acs (SeAcs) and inhibits its activity in a substrate-competitive manner. In addition, cAMP binding increases SeAcs acetylation by simultaneously promoting Pat-dependent acetylation and inhibiting CobB-dependent deacetylation, resulting in enhanced SeAcs inhibition. A crystal structure study and site-directed mutagenesis analyses confirmed that cAMP binds to the ATP/AMP pocket of SeAcs, and restrains SeAcs in an open conformation. The cAMP contact residues are well conserved from prokaryotes to eukaryotes, suggesting a general regulatory mechanism of cAMP on Acs.Acetyl-coenzyme A (acetyl-CoA) is a central metabolic intermediate that modulates the balance of anabolism and catabolism by functioning as the fuel for energy generation or as the precursor of lipogenesis for energy storage in many organisms (1). Acetyl-CoA is also deemed a second messenger for physiological regulation by supplying an acetyl group for protein acetylation (1, 2), an important mechanism of post-translational modification (PTM). Acetyl-coenzyme A synthetase (Acs) 5 (EC 6.2